Genetics of myasthenia gravis: A case-control association study in the hellenic population

Clinical and Developmental Immunology

Volumn 2012, Issue , 2012, Pages

  Zagoriti, Zoi ^a   Georgitsi, Marianthi ^a   Giannakopoulou, Olga ^a   Ntellos, Fotios ^a   Tzartos, Socrates J ^a,b   Patrinos, George P ^a   Poulas, Konstantinos ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; DNA BINDING PROTEIN; IL10 PROTEIN, HUMAN; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL PEPTIDE; TNFAIP3 PROTEIN, HUMAN;

ARTICLE; CASE CONTROL STUDY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HUMAN; IMMUNE FUNCTION TEST; MAJOR CLINICAL STUDY; MYASTHENIA GRAVIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; CAUCASIAN; ETHNOLOGY; FEMALE; GENETIC PREDISPOSITION; GENETICS; GREECE; MALE; PROMOTER REGION;

ADULT; AGED; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREECE; HUMANS; INTERFERON REGULATORY FACTORS; INTERLEUKIN-10; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYASTHENIA GRAVIS; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 84867870009     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/484919     Document Type: Article

References (32)

1. Kalamida D., Poulas K., Avramopoulou V., Fostieri E., Lagoumintzis G., Lazaridis K., Sideri A., Zouridakis M., Tzartos S. J., Muscle and neuronal nicotinic acetylcholine receptors: structure, function and pathogenicity. FEBS Journal 2007 274 15 3799 3845 2-s2.0-34447639624 10.1111/j.1742-4658.2007.05935. x
2. Hoch W., Mcconville J., Helms S., Newsom-Davis J., Melms A., Vincent A., Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nature Medicine 2001 7 3 365 368 2-s2.0-0035105784 10.1038/85520
3. Zhang B., Tzartos J. S., Belimezi M., Ragheb S., Bealmear B., Lewis R. A., Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis. Archives of Neurology 2012 69 4 445 451
4. Carr A. S., Cardwell C. R., McCarron P. O., McConville J., A systematic review of population based epidemiological studies in Myasthenia Gravis. BMC Neurology 2010 10, article 46 2-s2.0-77953633370 10.1186/1471-2377-10-46
5. Drachman D., Rose N., Mackay I., Myasthenia gravis. The Autoimmune Diseases 1999 3rd Academic Press 637 662 Chapter 31
6. Namba T., Brunner N. G., Brown S. B., Muguruma M., Grob D., Familial myasthenia gravis. Report of 27 patients in 12 families and review of 164 patients in 73 families. Archives of Neurology 1971 25 1 49 60 2-s2.0-0015084861
7. Pirskanen R., Genetic aspects in Myasthenia gravis. A family study of 264 Finnish patients. Acta Neurologica Scandinavica 1977 56 5 365 388 2-s2.0-0017729608
8. Marrie R. A., Sahlas D. J., Bray G. M., Familial autoimmune myastenia gravis: four patients involving three generations. Canadian Journal of Neurological Sciences 2000 27 4 307 310
9. Bogdanos D. P., Smyk D. S., Rigopoulou E. I., Mytilinaiou M. G., Heneghan M. A., Selmi C., Twin studies in autoimmune disease: genetics, gender and environment. Journal of Autoimmunity 2012 38 2-3 J156 J169
10. Christensen P. B., Jensen T. S., Tsiropoulos I., Sorensen T., Kjaer M., Hojer-Pedersen E., Associated autoimmune diseases in myasthenia gravis. A population-based study. Acta Neurologica Scandinavica 1995 91 3 192 195
11. Giraud M., Beaurain G., Yamamoto A. M., Eymard B., Tranchant C., Gajdos P., Garchon H. J., Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies. Neurology 2001 57 9 1555 1560 2-s2.0-0035856431
12. Vandiedonck C., Beaurain G., Giraud M., Hue-Beauvais C., Eymard B., Tranchant C., Gajdos P., Dausset J., Garchon H. J., Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthemia gravis and thymus hyperplasia. Proceedings of the National Academy of Sciences of the United States of America 2004 101 43 15464 15469 2-s2.0-7444238973 10.1073/pnas. 0406756101
13. Giraud M., Vandiedonck C., Garchon H. J., Genetic factors in autoimmune myasthenia gravis. Annals of the New York Academy of Sciences 2008 1132 180 192 2-s2.0-45249120631 10.1196/annals.1405.027
14. Kozyrev S. V., Alarcon-Riquelme M. E., The genetics and biology of Irf5-mediated signaling in lupus. Autoimmunity 2007 40 8 591 601 2-s2.0-37349039478 10.1080/08916930701510905
15. Graham D. S. C., Manku H., Wagner S., Reid J., Timms K., Gutin A., Lanchbury J. S., Vyse T. J., Association of IRF5 in UK SLE families identifies a variant involved in polyadenylation. Human Molecular Genetics 2007 16 6 579 591 2-s2.0-34247125683 10.1093/hmg/ddl469
16. Mancl M. E., Hu G., Sangster-Guity N., Olshalsky S. L., Hoops K., Fitzgerald-Bocarsly P., Pitha P. M., Pinder K., Barnes B. J., Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms: multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. Journal of Biological Chemistry 2005 280 22 21078 21090 2-s2.0-20444368020 10.1074/jbc.M500543200
17. Wartz I. E., O'Rourke K. M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D. L., Ma A., Koonin E. V., Dixit V. M., De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF- κ B signalling. Nature 2004 430 7000 694 699 2-s2.0-3943054838 10.1038/nature02794
18. Vereecke L., Beyaert R., van Loo G., The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends in Immunology 2009 30 8 383 391 2-s2.0-68149139538 10.1016/j.it.2009.05.007
19. Musone S. L., Taylor K. E., Lu T. T., Nititham J., Ferreira R. C., Ortmann W., Shifrin N., Petri M. A., Ilyas Kamboh M., Manzi S., Seldin M. F., Gregersen P. K., Behrens T. W., Ma A., Kwok P. Y., Criswell L. A., Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus. Nature Genetics 2008 40 9 1062 1064 2-s2.0-50449103533 10.1038/ng.202
20. Rowbottom A. W., Lepper M. A., Garland R. J., Cox C. V., Corley E. G., Interleukin-10-induced CD8 cell proliferation. Immunology 1999 98 1 80 89
21. Moore K. W., Malefyt R. D. W., Coffman R. L., O'Garra A., Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 2001 19 683 765 2-s2.0-0035062021 10.1146/annurev.immunol.19.1.683
22. Zhang G. X., Xiao B. G., Yu L. Y., Van der Meide P. H., Link H., Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR. Journal of Neuroimmunology 2001 113 1 10 18 2-s2.0-0035255077 10.1016/S0165-5728(00)00411-2
23. Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V., An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics 1997 24 1 1 8 2-s2.0-0031017238
24. Gregersen P. K., Olsson L. M., Recent advances in the genetics of autoimmune disease. Annual Review of Immunology 2009 27 363 391
25. Graham R. R., Kyogoku C., Sigurdsson S., Vlasova I. A., Davies L. R., Baechler E. C., Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proceedings of the National Academy of Sciences of the United States of America 2007 104 16 6758 6763
26. Levi B. Z., Hashmueli S., Gleit-Kielmanowicz M., Azriel A., Meraro D., ICSBP/IRF-8 transactivation: a tale of protein-protein interaction. Journal of Interferon and Cytokine Research 2002 22 1 153 160 2-s2.0-0036178323 10.1089/107999002753452764
27. Rechsteiner M., Rogers S. W., PEST sequences and regulation by proteolysis. Trends in Biochemical Sciences 1996 21 7 267 271
28. Plenge R. M., Cotsapas C., Davies L., Price A. L., de Bakker P. I., Maller J., Two independent alleles at 6q23 associated with risk of rheumatoid arthritis. Nature Genetics 2007 39 12 1477 1482
29. Mackay I. R., Clustering and commonalities among autoimmune diseases. Journal of Autoimmunity 2009 33 3-4 170 177
30. Wang W. Y., Barratt B. J., Clayton D. G., Todd J. A., Genome-wide association studies: theoretical and practical concerns. Nature Reviews Genetics 2005 6 2 109 118
31. Rioux J. D., Abbas A. K., Paths to understanding the genetic basis of autoimmune disease. Nature 2005 435 7042 584 589 2-s2.0-20444438369 10.1038/nature03723
32. Alseth E. H., Nakkestad H. L., Aarseth J., Gilhus N. E., Skeie G. O., Interleukin-10 promoter polymorphisms in myasthenia gravis. Journal of Neuroimmunology 2009 210 1-2 63 66 2-s2.0-67349177784 10.1016/j.jneuroim.2009. 02.009